Posted on 9th June 2014
Following the recommendation of the PDAC, Endolite has been working with CMS to establish a new code that adequately describes the function of the élan microprocessor foot system. In a preliminary decision CMS has verified that the élan meets the requirements of the L5973 code.At the annual CMS Public Meeting it was confirmed by Bonnie Brooks that Endolite should recommend the use of L5973 for coding the élan foot effective immediately. While the initial decisions are not generally official until notification in November, it was confirmed by chairperson Cynthia Hake that Bonnie Brook’s statement was, in effect, code verification from the insurer.
In accordance with their decision, Endolite suggests the use of L5973 for the élan foot. We will continue to work with CMS to establish an addition code to adequately describe the unique clinical benefits the élan provides the user beyond that described in the existing L5973 code. If you have any questions, please feel free to contact your Endolite territory manager or a member of our clinical staff.
When transcripts and links are available future updates will be posted on our website.